Image-Guided Radiotherapy Market Size, Share, Trends & Forecast

The Image Guided Radiotherapy Market is becoming increasingly important as cancer treatment moves toward greater precision and personalization. According to Market Research Future, the market was valued at USD 3.27 billion in 2024 and is projected to reach USD 5.53 billion by 2035, expanding at a 4.89% CAGR from 2025 to 2035. Growing cancer incidence, demand for personalized treatment, and advances in medical imaging are supporting this expansion.

Technology remains a major factor shaping the market. Computed tomography currently accounts for the largest technology segment because it supports accurate tumor localization and treatment planning. At the same time, magnetic resonance imaging is gaining momentum because its detailed soft-tissue visualization can help clinicians better assess tumors and surrounding structures during radiotherapy.

Applications are also expanding beyond basic tumor imaging. Tumor imaging currently represents the largest application, while radiotherapy planning is identified as the fastest-growing area as healthcare providers seek more accurate and individualized treatment protocols. Treatment verification is gaining attention as well, particularly with the development of adaptive radiotherapy and technologies designed to confirm accurate radiation delivery.

Hospitals remain the leading end users because they have the infrastructure and specialist teams needed to operate advanced imaging and radiotherapy systems. North America currently represents the largest regional market, with a value of about USD 1.56 billion in 2024, while Europe accounted for approximately USD 1.02 billion. Asia-Pacific is developing rapidly as healthcare infrastructure and investment in advanced cancer treatment continue to expand.

Looking ahead, opportunities will increasingly center on smarter and more connected radiotherapy systems. AI-assisted treatment planning, real-time imaging, adaptive therapy, and improved software integration can help providers deliver more personalized treatment workflows. Continued investment in oncology infrastructure and collaboration between healthcare institutions, technology companies, and research organizations should create further opportunities for image guided radiotherapy solutions.

Strengthen your strategy with data-backed research insights:

Flow Cytometer Reagents Market Share

Real-World Evidence Market Trends

Rapid Diagnostics Market Growth

Vacuum blood collection tube Market Demand

Hospital Services Market Volume

Read More
Lukoon https://lukoon.com